EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 337 filers reported holding EXELIXIS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,453,000 | +30.3% | 92,639 | +73.0% | 0.13% | +27.9% |
| Q2 2022 | $1,115,000 | +17.9% | 53,541 | +28.3% | 0.10% | +31.6% |
| Q1 2022 | $946,000 | +10.9% | 41,739 | -10.6% | 0.08% | +9.7% |
| Q4 2021 | $853,000 | +24.0% | 46,684 | +43.5% | 0.07% | +5.9% |
| Q3 2021 | $688,000 | +39.3% | 32,536 | +20.1% | 0.07% | +33.3% |
| Q2 2021 | $494,000 | +615.9% | 27,102 | +577.7% | 0.05% | +466.7% |
| Q1 2020 | $69,000 | 0.0% | 3,999 | +1.6% | 0.01% | -30.8% |
| Q4 2019 | $69,000 | -35.5% | 3,937 | -34.7% | 0.01% | -48.0% |
| Q3 2019 | $107,000 | +435.0% | 6,030 | +808.1% | 0.02% | +733.3% |
| Q4 2017 | $20,000 | +81.8% | 664 | +58.9% | 0.00% | +50.0% |
| Q3 2017 | $11,000 | – | 418 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |